Ledger.Open graph →
SEC Form D · filed November 28, 2022

Escient Pharmaceuticals Inc

Offering
$120.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Peter S. Hirth · San Mateo, CADirectorCharles S. Zuker · San Diego, CADirectorJason S. Hafler · San Diego, CADirectorKevin S. Raidy · San Diego, CADirectorJeenjoo S. Kang · San Diego, CADirectorAndrew S. Schwab · San Diego, CADirectorKathleen S. Glaub · San Mateo, CADirectorAaron S. Mishel · San Diego, CAExecJoshua Grass · New York, NYExec · DirectorMarcus Boehm · San Diego, CAExecPeter S. Hirth · San Mateo, CADirectorCharles S. Zuker · San Diego, CADirectorKathleen S. Glaub · San Mateo, CADirectorJason S. Hafler · San Diego, CADirectorKevin S. Raidy · San Diego, CADirectorAaron S. Mishel · San Diego, CAExecJoshua Grass · New York, NYExec · DirectorJeenjoo S. Kang · San Diego, CADirectorAndrew S. Schwab · San Diego, CADirectorMarcus Boehm · Minneapolis, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗